US BROKER MOVES: TMUS upgraded at Daiwa; HUN downgraded at JPM

• ZIM Integrated Shipping (ZIM) upgraded from Sell to Neutral at Citi; PT USD 31.80
• T-Mobile (TMUS) upgraded from Neutral to Outperform at Daiwa; PT USD 240
• Symbotic (SYM) upgraded from Neutral to Overweight at KeyBanc; PT USD 70
• QuantumScape (QS) upgraded from Sell to Hold at HSBC; PT USD 8.30
• Nicolet Bankshares (NIC) upgraded from Neutral to Overweight at Piper Sandler
• Neptune Insurance (NP) upgraded from Neutral to Outperform at KBW; PT USD 25
• LeonaBio Inc (LONA) upgraded from Neutral to Outperform at Mizuho Securities
• Garmin (GRMN) upgraded from Underweight to Equal-Weight at Morgan Stanley; PT USD 252
• Dentsply (XRAY) upgraded from Neutral to Buy at BofA; PT USD 17
• Cineverse Corp (CNVS) upgraded from Neutral to Buy at Benchmark; PT USD 12
• Chewy (CHWY) upgraded from Neutral to Outperform at Raymond James; PT USD 28

• SimilarWeb (SMWB) downgraded from Buy to Hold at Needham
• RF Industries (RFIL) downgraded from Buy to Neutral at B Riley; PT USD 10.25
• Polestar (PSNY) ADRs downgraded from Neutral to Underweight at Cantor
• Mister Car Wash (MCW) downgraded from Buy to Neutral at Mizuho Securities; PT USD 7
• Huntsman (HUN) downgraded from Overweight to Neutral at JPMorgan; PT USD 14
• HF Sinclair (DINO) downgraded from Outperform to Sector Perform at Scotiabank; PT USD 53
• Fiverr (FVRR) downgraded from Overweight to Neutral at JPMorgan; PT USD 15
• Cheesecake Factory (CAKE) downgraded from Overweight to Equal-Weight at Stephens; PT USD 65

• Tempus AI (TEM) initiated at Outperform at Mizuho Securities; PT USD 100
• Surrozen (SRZN) initiated at Overweight at Cantor; PT USD 40
• Rhythm Pharma (RYTM) initiated at Outperform at RBC; PT USD 145
• Perspective Therapeutics (CATX) initiated at Overweight at Piper Sandler
• Lear (LEA) initiated at Buy at Benchmark; PT USD 170
• Kiniksa Pharmaceuticals (KNSA) initiated at Buy at Canaccord; PT USD 62
• Grail (GRAL) initiated at Hold at TD Cowen; PT USD 114
• Fossil (FOSL) initiated at Outperform at Northland; PT USD 7
• Credo Technology (CRDO) initiated at Buy at Goldman; PT USD 165
• BioHarvest Sciences Inc (BHST) initiated at Buy at Roth Capital Partners
• Axogen (AXGN) initiated at Overweight at Wells Fargo; PT USD 40

Daiwa's upgrade of T-Mobile (TMUS) from Neutral to Outperform signals increased confidence in the stock's potential, with a target price set at $240, suggesting strong future growth prospects. Conversely, Huntsman's downgrade by JPMorgan from Overweight to Neutral could indicate potential headwinds for the company, which may affect market perception and share performance in the near term, particularly in a volatile economic environment.